Sheel Biotech Ltd

Sheel Biotech Legal & Regulatory

SEBI issued an advisory letter to Sheel Biotech Limited for delayed disclosure of a monitoring agency report. No monetary penalty or restrictions were imposed on the company.

Sheel Biotech Annual General Meeting

Sheel Biotech Limited held its 35th Annual General Meeting on September 24, 2026. The meeting covered adoption of financial statements and approval of other ordinary resolutions.

Sheel Biotech Other Announcement

Sheel Biotech intimated that its Statutory Auditor Shyam Sunder Mangla & Co LLP has changed its name to S S Mangla & Co LLP effective 18 December 2025. No change in the auditor appointment itself.

Sheel Biotech Bags ₹14.53 Cr Order

Sheel Biotech Limited has finalised a commercial transaction for its Blueberry project, valued at ₹14.53 Crore. This contract marks a significant business development for the company.

Value

₹14.53 Cr

Sheel Biotech Annual General Meeting

Sheel Biotech Limited scheduled its 35th Annual General Meeting for September 24, 2026. The company also announced the record date and book closure period.

Sheel Biotech Earnings Call: Key Takeaways

Sheel Biotech is pivoting into the high-margin blueberry market, targeting ₹110 Cr+ revenue for FY26 using its established tissue culture and greenhouse infrastructure.

Call

Guides 10% growth

Sheel Biotech H2 FY26 Results: Net Profit ₹11.6 Cr, Down 20.0% YoY

Sheel Biotech Ltd reported revenue from operations of ₹88.2 Cr (-2.5% YoY) and net profit of ₹11.6 Cr (-20.0% YoY) for H2 FY26.

Key figure

Net profit ₹11.6 Cr · -20.0% YoY